Accordingly, in some studies [48, 49], it was shown that infiltrative FVPTCs are characterized by a higher incidence of the BRAF V600E mutation and RET-PTC translocations but a lower frequency of RAS mutations in comparison with encapsulated FVPTC. The gene discussed is BRAF; the disease is follicular variant thyroid gland papillary carcinoma.